Shares of Cardinal Health, Inc. (NYSE:CAH – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the fourteen ratings firms that are presently covering the stock, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and ten have given a buy recommendation to the company. The average 1-year price target among brokers that have updated their coverage on the stock in the last year is $146.43.
Several research analysts recently commented on the stock. Morgan Stanley lifted their target price on shares of Cardinal Health from $142.00 to $166.00 and gave the stock an “overweight” rating in a research note on Monday, May 5th. UBS Group lifted their target price on shares of Cardinal Health from $150.00 to $160.00 and gave the stock a “buy” rating in a research note on Tuesday, April 29th. Mizuho lifted their target price on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an “outperform” rating in a research note on Monday, March 31st. Bank of America lifted their target price on shares of Cardinal Health from $150.00 to $155.00 and gave the stock a “buy” rating in a research note on Friday, April 11th. Finally, Robert W. Baird lifted their target price on shares of Cardinal Health from $156.00 to $170.00 and gave the stock an “outperform” rating in a research note on Friday, May 2nd.
Get Our Latest Stock Analysis on Cardinal Health
Institutional Trading of Cardinal Health
Cardinal Health Stock Performance
Shares of CAH opened at $153.93 on Tuesday. The firm has a market cap of $36.74 billion, a price-to-earnings ratio of 28.72, a PEG ratio of 1.49 and a beta of 0.66. Cardinal Health has a fifty-two week low of $93.17 and a fifty-two week high of $156.44. The firm has a 50 day moving average price of $141.26 and a 200-day moving average price of $130.05.
Cardinal Health (NYSE:CAH – Get Free Report) last announced its quarterly earnings data on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.15 by $0.20. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. During the same period in the previous year, the business posted $2.08 EPS. The business’s quarterly revenue was up .0% on a year-over-year basis. As a group, equities research analysts predict that Cardinal Health will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a dividend of $0.5107 per share. This represents a $2.04 dividend on an annualized basis and a dividend yield of 1.33%. The ex-dividend date is Tuesday, July 1st. This is a boost from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is 31.83%.
About Cardinal Health
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Read More
- Five stocks we like better than Cardinal Health
- Insider Selling Explained: Can it Inform Your Investing Choices?
- Hormel Stock Near Lows, But Tariff Relief Could Boost Outlook
- Consumer Discretionary Stocks Explained
- 3 Different Ways to Add Gold to Your Portfolio
- Comparing and Trading High PE Ratio Stocks
- Coca-Cola Stock Has Momentum, PepsiCo May Be the Better Buy
Receive News & Ratings for Cardinal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardinal Health and related companies with MarketBeat.com's FREE daily email newsletter.